Cineromycin B

Cineromycin B
Names
	IUPAC name (3Z,5R,6Z,8S,9Z,13S,14R)-5,8-dihydroxy-5,9,13,14-tetramethyl-1-oxacyclotetradeca-3,6,9-trien-2-one
Identifiers
CAS Number	11033-23-1 ;
3D model (JSmol)	Interactive image;
ChemSpider	4948482;
PubChem CID	6444600;
	InChI InChI=1S/C17H26O4/c1-12-6-5-7-13(2)15(18)8-10-17(4,20)11-9-16(19)21-14(12)3/h7-12,14-15,18,20H,5-6H2,1-4H3/b10-8-,11-9-,13-7-/t12-,14+,15-,17+/m0/s1 Key: RLNOIXQIRICASI-HTNMZXOESA-N;
	SMILES C[C@H]1CC/C=C(\[C@H](/C=C\[C@@](/C=C\C(=O)O[C@@H]1C)(C)O)O)/C;
Properties
Chemical formula	C17H26O4
Molar mass	294.391 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Cineromycin B is an antiadipogenic antibiotic with the molecular formula C₁₇H₂₆O₄ which is produced by the bacterium Streptomyces cinerochromogenes.^[1]^[2]^[3]^[4]

References

1 2 "Cineromycin B". Pubchem.ncbi.NLM.nih.gov.
↑ Matsuo, Hirotaka; Kondo, Yoshiyuki; Kawasaki, Takashi; Imamura, Nobutaka (August 2015). "Cineromycin B isolated from Streptomyces cinerochromogenes inhibits adipocyte differentiation of 3T3-L1 cells via Krüppel-like factors 2 and 3". Life Sciences. 135: 35–42. doi:10.1016/j.lfs.2015.05.020. PMID 26092481.
↑ Rai, Amit K.; Singh, Sudhir P.; Pandey, Ashok; Larroche, Christian; Soccol, Carlos Ricardo (30 November 2021). Current Developments in Biotechnology and Bioengineering: Technologies for Production of Nutraceuticals and Functional Food Products. Elsevier. p. 359. ISBN 978-0-12-823643-7.
↑ Parte, Aidan; Whitman, William B.; Goodfellow, Michael; Kämpfer, Peter; Busse, Hans-Jürgen; Trujillo, Martha E.; Ludwig, Wolfgang; Suzuki, Ken-ichiro (23 June 2012). Bergey's Manual of Systematic Bacteriology: Volume 5: The Actinobacteria. Springer Science & Business Media. p. 1607. ISBN 978-0-387-68233-4.